R Jeffrey Bailly, Executive Chairman of UFP Technologies Inc. ($UFPT), sold 6,866 shares of company stock on August 10, 2026, at a price of $316.58 per share. The open-market transaction carried a total value of $2,173,638.28, according to a Form 4 filing submitted to the Securities and Exchange Commission on August 11, 2026, one day after the trade.
The sale was one of three open-market disposals Bailly executed on the same day, with each successive transaction carrying a slightly higher share price. He first sold 5,771 shares at $315.53 each, totaling $1,820,923.63. He then sold 6,866 shares at $316.58 each, the $2.17 million transaction. The third sale involved 374 shares at $317.27 each, totaling $118,658.98. Across the three transactions, Bailly sold 13,011 shares for an aggregate value of approximately $4.11 million. Following the sales, his directly held position in UFP Technologies fell to zero.
Bailly's August 10 sales were the latest in a series of insider sales at UFP Technologies during 2026. On August 6, the company's President sold 1,100 shares at $317.00 per share, a transaction valued at $348,700. Earlier in the year, two directors also reported open-market sales. On June 12, 2026, a director sold 1,200 shares across two transactions for a combined $287,149. On May 12, 2026, another director reported a sale of 2,864 shares at $221.71 per share, totaling $634,977.44.
Insider selling on $UFPT stock was also recorded during the second half of 2025. Former President Christopher P. Litterio executed a series of ten open-market sales on November 6, 2025, disposing of 1,829 shares across those transactions at prices ranging from $219.82 to $232.29 per share. The combined total of the ten sales was $415,549.65. On December 10, 2025, the company's President sold an additional 100 shares at $213.58 per share, a $21,358 transaction. Those trades followed a pair of disposals by a director on September 5, 2025, in which 2,873 shares were sold for a combined $591,883.
The cluster of insider sales on $UFPT spans from September 2025 through August 2026, encompassing transactions by the Executive Chairman, the President, the former President, and two directors. Every filing in the review period reported open-market sales. No insider purchases or equity grant acceptances appeared in the SEC records for UFP Technologies during this timeframe. No member of Congress reported trading the company's shares.
UFP Technologies, headquartered in Newburyport, Massachusetts, designs and manufactures custom-engineered components, primarily for the medical device and sterile packaging markets. The company had a market capitalization of approximately $2.43 billion at the time of the August 10 filing. The Form 4 arrived at the SEC one day after the transaction date.